The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of regorafenib (Reg) in patients with previously treated advanced pancreatic cancer (APC).
 
John Stuart Salmon
Stock and Other Ownership Interests - Abbvie; Array BioPharma; Clovis Oncology; Gilead Sciences
Research Funding - Bayer Schering Pharma (Inst)
 
Jimmy J. Hwang
Consulting or Advisory Role - Amgen; Bayer; Genentech/Roche; Merrimack; Sanofi; Taiho Pharmaceutical
Speakers' Bureau - Amgen; Bayer/Onyx; Celgene; Genentech/Roche
Expert Testimony - Roche
 
Myra M. Robinson
No Relationships to Disclose
 
James Thomas Symanowski
Consulting or Advisory Role - Endocyte (Inst); Lilly; Ra Pharma (Inst)
Research Funding - Bayer (Inst); Celgene (Inst); Novocure (Inst); Pfizer (Inst)
 
Lloye M Dillon
Employment - OncoTab
 
Lopamudra Das Roy
Employment - OncoTab
 
Matthew A. Beldner
No Relationships to Disclose
 
Kelry Preston
No Relationships to Disclose
 
Sharon Buige
No Relationships to Disclose
 
Reza Nazemzadeh
No Relationships to Disclose
 
Pinku Mukherjee
Leadership - OncoTab
 
Farhang Farhangfar
No Relationships to Disclose
 
Edward S. Kim
Honoraria - AstraZeneca; Boehringer Ingelheim; Celgene; Lilly
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Celgene; Lilly